Page 3 - இதய சமூகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID vaccines: Heart inflammation warning added to Pfizer jab

COVID vaccines: Heart inflammation warning added to Pfizer jab
theage.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theage.com.au Daily Mail and Mail on Sunday newspapers.

New zealandChris semsarianSociety of australiaTherapeutic goods administrationDisease controlProfessor chris semsarianCardiac societyபுதியது ஜீலாந்துசமூகம் ஆஃப் ஆஸ்திரேலியாநோய் கட்டுப்பாடுஇதய சமூகம்

COVID vaccines: Heart inflammation warning added to Pfizer jab

COVID vaccines: Heart inflammation warning added to Pfizer jab
brisbanetimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from brisbanetimes.com.au Daily Mail and Mail on Sunday newspapers.

Review Shows Over Half of CVD Deaths Worldwide Occur in Asia - American College of Cardiology

Review Shows Over Half of CVD Deaths Worldwide Occur in Asia - American College of Cardiology
acc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acc.org Daily Mail and Mail on Sunday newspapers.

United statesDong zhaoSouth koreaJianan wangValentin fusterJournal of the american college cardiologySingapore cardiac societySouthern asiaEditor in chief jian an wangChief valentin fusterAnnual scientific meetingCardiac societyAnnual scientific meeting virtualAsia editor in chief jian an wangAmerican collegeNothing left behind

Heart failure: Optimised use of new drugs offers solutions to old problems

References 1. Betty B, Fisher R. Optimising heart failure management: What GPs need to know. Goodfellow Symposium, 28 March 2021. goodfellowunit.org 2. Teh R, Kerse N, Kepa M, et al. Self-rated health, health-related behaviours and medical conditions of Maori and non-Maori in advanced age: LiLACS NZ. N Z Med J 2014;127(1397):13–29. 3. Hayman S, Atherton JJ. Should angiotensin receptor neprilysin inhibitors replace angiotensin-converting enzyme inhibitors in heart failure with a reduced ejection fraction? Card Fail Rev 2016;2(1):47–50. 4. Atherton JJ, Sindone A, De Pasquale CG, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the prevention, detection, and management of heart failure in Australia 2018. 

New zealandSociety of australiaNational heart foundation of australiaCard fail revHeart foundationCardiac societyHeart lung circபுதியது ஜீலாந்துசமூகம் ஆஃப் ஆஸ்திரேலியாதேசிய இதயம் அடித்தளம் ஆஃப் ஆஸ்திரேலியாஇதயம் அடித்தளம்இதய சமூகம்

Nationwide dispensing of cardioprotective medications during the first year following acute coronary syndrome (ANZACS-QI 56)

Nationwide dispensing of cardioprotective medications during the first year following acute coronary syndrome (ANZACS-QI 56) Open Access PDF Download Unless contraindicated, the current guidelines for secondary prevention following acute coronary syndrome (ACS) recommend a statin for all patients. Patients should also receive combination antithrombotic therapy usually a combination of aspirin and a PY212 inhibitor antiplatelet agent. But, for patients with atrial fibrillation, an oral anticoagulant may be added or substituted for an antiplatelet agent. For most patients, a beta-blocker and an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACE-I/ARB) are also indicated. These medications have been shown to reduce mortality and improve outcomes after ACS.1–8

New zealandUnited statesNorthern regionUniversity of otagoMinimal risk health researchSociety of new zealandUniversity of otago human ethics committee healthRegion ethics committeeResearch advisor kaitohutohu rangahauNational heart foundation of australiaMyocardial infarctionAppendix figureOtago human ethics committeeNorthern region ethicsMulti region ethics committeeAppendix table